Dow Up0.15% Nasdaq Up0.21%

More On SPL.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Starpharma Holdings Limited (SPL.AX)

-ASX
0.71 0.00(0.00%) 2:11AM EDT
ProfileGet Profile for:
Starpharma Holdings Limited
Baker IDI Building
75 Commercial Road
Melbourne, VIC 3004
Australia - Map
Phone: 61 3 8532 2700
Fax: 61 3 9510 5955
Website: http://www.starpharma.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:N/A

Business Summary 

Starpharma Holdings Limited researches, develops, and commercializes dendrimer products for pharmaceutical, life-science, and other applications primarily in Australia. The company focuses on the development of VivaGel, a microbicidal agent in Phase III clinical trials for the management and prevention of bacterial vaginosis, and as a condom coating for prevention of sexual transmitted infections. It also develops dendrimer-enhanced, or DEP versions of existing drugs, including DEP docetaxel in Phase I clinical trial for breast, prostate, lung, and ovarian tumor; and agrochemicals. Starpharma Holdings Limited was founded in 1996 and is headquartered in Melbourne, Australia.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Starpharma Holdings Limited

Key Executives 
 PayExercised
Dr. Jacinth K. Fairley B.Sc., B.V.Sc.(Hons), MBA, 51
Chief Exec. Officer and Exec. Director
678.00K0.00
Mr. Nigel J. Baade B.Com, CPA, Grad. Dip. Arts,
Chief Financial Officer and Company Sec.
286.00K0.00
Dr. Jeremy R. Paull BSc (Hons), Ph.D.,
VP of Devel. & Regulatory Affairs
266.00K0.00
Dr. C. Paul Barrett B.Sc. (Hons), Ph.D.,
VP of Bus. Devel.
279.00K0.00
Dr. David J. Owen BSc(Hons) Ph.D.,
VP of Research
282.00K0.00
Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in AUD.